Regeneron Rallies After Seeking Emergency-Use Approval For Antibody Cocktail Hailed As "Cure" By Trump
October 08, 2020 at 08:05 AM EDT
Shares of Regeneron are ripping higher Thursday in premarket trading, building on its gains from Wednesday evening, after the company submitted its COVID-19 antibody cocktail to the FDA for emergency-use approval.
